Retatrutide is a next-generation triple agonist peptide targeting GIP, GLP-1, and glucagon receptors simultaneously. It represents the cutting edge of metabolic peptide science, offering superior weight loss, appetite control, and metabolic health benefits.
Triple receptor agonist: GIP, GLP-1, and glucagon
Superior weight loss and appetite suppression
Supports metabolic health and blood sugar regulation
